Human papillomavirus (HPV) infections play a crucial role in the pathogenesis of cervical neoplasia. Insights into the mechanisms by which HPV infection can, in a small numbers of cases, result in malignancy, comes from the observation that three proteins encoded by high-risk genital HPVs, E6, E7 and to a lesser extent E5, target factors that control the cell cycle and proliferation. These interactions result in abrogation of cell cycle control, chromosomal alterations, telomerase activation, and eventual cell immortalization. In this review, we discuss the functions of E6, E7, and E5 proteins that are most relevant to the malignant progression of HPV-transformed cells.
Human papillomaviruses (HPVs) are small doublestranded DNA viruses that induce hyperproliferative lesions of cutanous and mucosal epithelia. Of the more than 100 identified types of HPVs, approximately 30 specifically infect the genital epithelium (zur Hausen, 2002) . Genital papillomavirus infections can be passed between individuals through sexual contact, and represent one of the most common sexually transmitted diseases. Some HPV types like 6 and 11 induce only benign warts in the genital tract (condylomata acuminatum). They are referred to as low-risk types, as they induce lesions at low-risk for progression to malignancy. In contrast, the high-risk HPV types are associated at a high frequency with the development of malignant lesions. Approximately 99% of cervical cancers contain HPV DNA of the high-risk types (Walboomers et al., 1999) , with type HPV16 being the most prevalent, followed by types 18, 31, 33, and 45 (Laimins, 1993; de Villiers, 1994; zur Hausen and de Villiers, 1994) . It is important to note that not every woman infected with HPVs is destined to develop cervical cancer; in fact, HPV infection is very prevalent, while cervical cancer is not (Hildesheim et al., 1994) . Nevertheless, it is generally accepted that persistent high-risk HPV infection is the most important factor in the development of cervical neoplasia (zur Hausen, 1996; Wallin et al., 1999) .
Epidemiology
Cervical cancer is one of the most common cancers worldwide, accounting for 6% of all malignancies in women (Parkin et al., 2001) . About 470 000 new cases are diagnosed each year, and this occurs predominantly among the economically disadvantaged, in both developing and industrialized nations (Parkin et al., 2001) . Approximately 230 000 women die from invasive cervical cancer every year (Parkin et al., 2001) . The mean age for development of cervical cancer is 52 years and the distribution of cases is biphasic with peaks at 35-39 and 60-64 years (Boring et al., 1994) . The majority of all cervical carcinomas are squamous cell carcinomas (85-90%). The precursor lesions to cervical cancers are known as cervical intraepithelial neoplasia (CIN), and are generally diagnosed in younger women (van Oortmarssen and Habbema, 1995) . This demonstrates the significant time lag between infection and development of invasive cervical cancer.
The HPV genome
The genomes of all HPV types contain approximately eight open reading frames (ORF), which are transcribed as polycistronic messages from a single DNA strand (Figure 1 ). Regulatory sequences required for viral replication and transcription are concentrated in a noncoding region termed as the upstream regulatory region (URR). The gene products can be divided into two classes: early and late. The early proteins (E) in high-risk HPV types are expressed from the early promotor (P 97 in HPV31) prior to productive replication, while the late proteins (L) are expressed from the late promotor (P 742 in HPV31) during the synthesis of new virions. The early proteins E1 and E2 are necessary for viral DNA replication and bind as a complex to sequences around the origin of replication (Mohr et al., 1990; Ustav and Stenlund, 1991; Chiang et al., 1992; Frattini and Laimins, 1994) . E2 has also been suggested to have repressor activity on viral early promoter and this may function as part of a copy control mechanism (Thierry and Yaniv, 1987; Stubenrauch et al., 1998; Howley and Lowy, 2001) . E4 is expressed as a fusion protein with five amino acids from the N-terminus of E1 (E1, E4) and has been suggested to be involved in the alteration of cytoskeleton network (Doorbar et al., 1991) . The function of the E5 gene is largely unknown, but appears to encode a membrane protein with a weak transforming activity (Leptak et al., 1991) . E6 and E7 are the main transforming proteins of the high-risk HPV types and act by modulating the activities of cellular proteins that regulate the cell cycle (Phelps et al., 1988; Munger et al., 1989b; Scheffner et al., 1990; Werness et al., 1990) . Two late genes L1 and L2 encode capsid proteins.
The HPV life cycle
The productive life cycle of HPVs is directly linked to the epithelial cell differentiation (Figure 2 ). Infection by papillomaviruses is believed to occur through microtraumas in the epithelium, exposing the basal cells to entry by viruses. Following the entry into keratinocytes in the basal layer, HPV genomes are established as episomes at approximately 50 copies per cell, which replicate in synchrony with the cellular DNA replication (Howley and Lowy, 2001; Stubenrauch and Laimins, 1999) . The establishment and maintenance of HPV genomes are associated with expression of early HPV transcripts that encode the oncoproteins E6, E7, and E5 as well as the replication proteins E1 and E2. Following cell division, infected daughter cells leave the basal layer, migrate towards the suprabasal regions and begin to differentiate. In contrast to uninfected keratinocytes, which exit the cell cycle as soon as they detach from the basement membrane, HPV-infected cells enter into S phase after reaching the suprabasal layer (Doorbar et al., 1997) . This entry into S phase results in amplification of the viral genomes to thousands of copies per cell (Lambert, 1991) . Concurrent with the viral DNA amplification is the synthesis of E1, E4 proteins along with capsid proteins resulting in the assembly of infectious virions. Subsequently, virions are released into the environment as the upper layer of the epithelium is shed (Laimins, 1996) . In low-grade cervical lesions, the HPV genomes are found exclusively as episomal DNA molecules. In contrast, in cervical carcinomas, high-risk HPV genomes are often found integrated into the cellular host DNA (Figure 3 ) (Schwarz et al., 1985; Stoler et al., 1992) . HPV DNA integration has been suggested to be an important event in the development of cervical cancer, since this often results in a disruption of the E2 region (Schwarz et al., 1985; Baker et al., 1987) . Integration thus abrogates the inhibitory actions of the E2 proteins on the viral promoter of the E6 and E7 genes. This results in high-level expression of E6 and E7, and most likely contributes to cellular transformation that eventually results in cancer (Schneider-Gadicke and Schwarz, 1986; Smotkin and Wettstein, 1986; Androphy et al., 1987; Banks et al., 1987; Jeon et al., 1995) .
Cell transformation by HPV oncogenes
The ability of HPV infections to progress to malignancies has been attributed to the actions of the E6 and E7 proteins and their ability to manipulate cell cycle regulators. Expression of the high-risk HPV E6 and E7 proteins is sufficient to induce immortalization of primary human keratinocytes (HFKs) in tissue culture systems (Hawley-Nelson et al., 1989; Munger et al., 1989a; Hudson et al., 1990) . These cell lines, however, are not tumorigenic in nude mice and require additional events like the presence of activated ras-oncogene (Hurlin et al., 1991) or extended passaging in tissue culture (DiPaolo et al., 1989; Durst et al., 1989) to become fully transformed. These observations likely mimic the multistep process that is required for progression of HPV-induced tumorigenicity from initial infection to malignant transformation in vivo. In contrast to oncogenic HPV types, the E6 and E7 proteins from low-risk HPV types are unable to immortalize keratinocytes in vitro though they may moderately extend their life span (Thomas et al., 2001) .
Activities of the high-risk HPV E6 protein
E6 is one of the first genes expressed during HPV infection (Ozbun, 2002) and plays an important role in cellular immortalization. While E6 by itself is not capable of immortalizing HFKs, it acts together with E7 to induce changes leading to immortalization (Kiyono et al., 1998; Liu et al., 1999) . The E6 proteins have no intrinsic enzymatic activities and exert their functions by interacting with cellular proteins. E6 proteins are approximately 150 amino acids in size and contain four C-x-x-C motifs, which form two zincbinding domains. One important function of high-risk E6 proteins is the binding of the tumor suppressor p53, which results in its ubiquitin-mediated degradation. p53 is a site-specific DNA binding protein that is expressed in response to DNA-damaging agents or unscheduled induction of DNA replication resulting in cell cycle arrest or apoptosis (Harper et al., 1993; Lowe et al., 1994; Wu and Levine, 1994) . Since HPV depends on the cellular DNA synthesis machinery and must stimulate Sphase progression for the replication of their genome, overexpression of p53 represents a major impairment for viral replication (Lepik et al., 1998; Lepik and Ustav, 2000) . To degrade p53, the E6 proteins from high-risk HPV types first bind to a cellular ubiquitin-ligase, the E6-associated protein (E6-AP), which, in a complex with E6, is then able to bind the p53 protein . E6-AP then recruits the ubiquitin complex of enzymes, which ubiquitinates lysines on p53 initiating its proteolysis by the proteasome . The degradation of p53 by high-risk E6 results in bypassing the normal growth arrest signals at the G 1 /S and G 2 /M checkpoints leading to the acquisition of numerous genetic alterations that contribute to malignant transformation.
In addition to targeting p53 for degradation, E6 proteins from high-risk HPV types activate telomerase (Klingelhutz et al., 1996) . Telomerase is a multisubunit enzyme responsible for replicating telomeric DNA at the ends of chromosomes. Activation of telomerase is a critical step in cellular transformation (Hahn et al., 1999; Elenbaas et al., 2001) . In most normal somatic cells, telomerase activity is absent, and this results in a gradual loss of telomeres through successive cell divisions. It has been suggested that critically shortened telomeres initiate the natural pathway leading to senescence and cell death (Harley, 1991; Allsopp and Harley, 1995; Reddel, 1998; Liu, 1999) . In contrast, most tumor cells maintain telomere length and telomerase activity (Counter et al., 1992; Kim et al., 1994; Bryan et al., 1997) . Regulation of telomerase activity has been shown to occur primarily through the level of expression of the human telomerase reverse transcriptase (hTert) gene, encoding the telomerase catalytic subunit (Meyerson et al., 1997; Counter et al., 1998; Nakayama et al., 1998) . Recently, it has been shown that expression of hTert is sufficient to induce immortalization of fibroblast cells (Bodnar et al., 1998; Liu, 1999) but not keratinocytes, the natural host of HPV. Immortalization of keratinocytes requires activation of hTert and the p16 pathway (Kiyono et al., 1998; Dickson et al., 2000) . The precise mechanism of telomerase activation by E6 is unknown, however, several studies demonstrated that E6 can upregulate the steady-state levels of endogenous hTert in keratinocytes by transcriptional activation of its promotor (Gewin and Galloway, 2001; Oh et al., 2001; Veldman et al., 2001) . Interestingly, this mechanism seemed to be p53-independent, and may involve the myc activator (Gewin and Galloway, 2001; Oh et al., 2001) .
Other p53-independent functions of E6 likely contribute to its activities in transformation. One of these is the interaction of high-risk E6 proteins with several PDZ domain-containing proteins like hDlg (Kiyono et al., 1997; Lee et al., 1997; Gardiol et al., 1999) , hScrib (Nakagawa and Huibregtse, 2000) , MUPP1 , and MAGI-1, -2, -3 Thomas et al., 2002) resulting in their ubiquitinmediated degradation. PDZ domains consist of approximately 90-amino-acid long protein-protein interaction units and are most often found within the cellular proteins located at areas of cell-cell contact, such as synaptic junctions in neurons and tight junctions in epithelial cells (Fanning and Anderson, 1999) . It is suggested that PDZ proteins act as molecular scaffolds that function in signal transduction (Gomperts, 1996; Craven and Bredt, 1998; Mitic and Anderson, 1998) . Several viral proteins involved in oncogenesis like adenovirus E4-ORF1, HTLV-1Tax as well as high-risk HPV E6 proteins possess PDZ domain-binding motifs at their extreme carboxyl-termini (Lee et al., 1997) . Mutation of this PDZ-binding domain in high-risk E6 proteins has been shown to abrogate its transforming functions (Kiyono et al., 1997; Lee et al., 1997) .
Activities of the high-risk HPV E7 protein
The E7 protein together with E6 provide the major transforming activity of HPVs. Expression of the E7 protein in the absence of other viral gene products leads to the transformation of rodent fibroblasts. While E7 alone can immortalize human keratinocytes, the presence of E6 greatly enhances the frequency at which this can occur (Bedell et al., 1989; Halbert et al., 1991) . E7 proteins of the high-risk types are primarily nuclear proteins of approximately 100 amino acids in length that dimerize through a zinc-finger motif in the C-terminus (Howley and Lowy, 2001 ). The primary activity of highrisk E7 proteins is its association with members of the retionoblastoma (Rb) tumor repressor family to facilitate progression into S phase (reviewed in Vousden, 1994) . The Rb proteins play an important role in cell cycle regulation promoting the transition from G 1 into S phase. In normal cells, Rb is hypophosphorylated in early G 1 and becomes increasingly phosphorylated towards S phase. In its hypophosphorylated form, Rb binds E2F transcription factors and actively represses transcription from promoters containing E2F sites (reviewed in Weinberg, 1995) . A large number of genes required for DNA synthesis, such as DNA polymerase alpha and thymidine kinase, are transcribed in a cell cycle-dependent manner because of regulation by E2F (La Thangue, 1994; Slansky and Farnham, 1996) . By binding Rb in a hypophosphorylated state, E7 prevents it from binding to E2F and thereby promoting cell cycle progression (Chellappan et al., 1991) . In normal epithelia, cell cycle exit occurs following differentiation and is believed to be mediated in large part by the action of the Rb protein. By binding to Rb, E7 promotes cell cycle progression in differentiated epithelial cells, allowing for productive replication of HPV genes. Additionally, the E7-induced ubiquitin-mediated degradation of Rb appears to be essential to efficiently overcome cell cycle arrest (Giarre et al., 2001) . Interestingly, the E7 protein of the low-risk type HPV-1 is able to bind Rb, but fails in targeting it for degradation (Giarre et al., 2001) . Besides Rb, E7 interacts with two other members of the same family, p107 and p130, which also negatively regulate E2F transcription (Dyson et al., 1989; Davies et al., 1993) .
Additional studies with E7 from high-risk HPV types have demonstrated its ability to abrogate the inhibitory activities of the cyclin-dependent kinase inhibitors (CKIs) such as p21 (Funk et al., 1997; and p27 (Zerfass-Thome et al., 1996) . Recently, it has been shown that inactivation of both the Rb protein and p21 by E7 is necessary to prevent cell cycle arrest (Helt et al., 2002) . The binding of p21 and p27 by E7 interferes with the ability of p53 to induce G 1 growth arrest following DNA damage (Demers et al., 1994a; Hickman et al., 1994; Slebos et al., 1994) . Interestingly, E7-expressing cells contain increased steady-state levels of p53 (Demers et al., 1994b) and p21 (Thomas and Laimins, 1998) , which is not a consequence of transcriptional induction, but rather to protein stabilization Jones et al., 1999; Noya et al., 2001) . The presence of high-risk E6 proteins acts to reduce the elevated levels of p53 induced by E7.
Activities of the high-risk HPV E5 protein
The BPV-1 E5 protein is the primary transforming protein in bovine papillomaviruses (BPV), functioning through cellular growth factor receptors like the platelet-derived growth factor (PDGFR) (Petti et al., 1991) and in transient assays with the eipdermal growth factor receptor (EGFP) (Martin et al., 1989) . In contrast to BPV E5, the HPV E5 protein exhibits only weak transforming activity (Leechanachai et al., 1992; Bouvard et al., 1994; Valle and Banks, 1995) . The high-risk HPV E5 genes encode highly hydrophobic proteins of around 80 amino acids in length (Bubb et al., 1988; Halbert and Galloway, 1988) , which are localized mainly to the endosomal membranes, Golgi apparatus and to a lesser extent, the plasma membranes (Conrad et al., 1993) . It has been shown that the E5 protein from high-risk HPV types increases cellular growth of mouse fibroblasts and can transform them to anchorageindependent growth (Valle and Banks, 1995) . In addition, E5 increases the proliferative capacity of human keratinocytes that is further enhanced by addition of epidermal growth factor (EGF) (Crusius et al., 1998; Valle and Banks, 1995) . Additional studies have demonstrated that E5 expression results in an ligand-dependent increase in the levels of EGFR phosphorylation (Pim et al., 1992; Straight et al., 1993) and enhances mitogenic signaling from EGFRs (Leechanachai et al., 1992; Gu and Matlashewski, 1995; Crusius et al., 1997 Crusius et al., , 1998 . In HPV E5-expressing cells, E5 proteins also bind to the 16 kDa subunit of the vacuolar ATPase, interfering thereby with the acidification of the endosomes (Straight et al., 1995) . The inhibition of pH change results in an enhanced turnover of the EGFR to the plasma membrane and is suggested to 4 prolong signaling by the EGFR/EGF complex (Straight et al., 1995) . Recent studies examining the effects of mutating E5 in the context of the complete HPV genome demonstrated an important activity in regulating the amplification and late gene expression in differentiated suprabasal cells. Interestingly, E5 in this context was found to minimally influence the levels of EGFR or its phosphoryation status (Fehrmann et al., 2003) . This suggests that the HPV E5 protein acts in the late phase of the viral life cycle, most likely in conjunction with E7, to support cell cycle progression.
Summary
Recent efforts in the study of HPVs have identified the principle cellular targets of E6 and E7 proteins from the high-risk HPV types. These include p53, telomerase and PDZ proteins for E6 and the Rb family of proteins along with p21 and p27 for E7. A clear picture is beginning to emerge as to how the targeting of these cell cycle regulators by HPV gene products results in malignant transformation. Less is known about how the E5 protein functions and further efforts in this area are of high importance.
